| Literature DB >> 30775046 |
Pinar Arican1, Nihal Olgac Dundar2, Berk Ozyilmaz3, Dilek Cavusoglu2, Pinar Gencpinar2, Kadri Murat Erdogan3, Merve Saka Guvenc3.
Abstract
Chromosomal microarray (CMA) analysis for discovery of copy number variants (CNVs) is now recommended as a first-line diagnostic tool in patients with unexplained developmental delay/intellectual disability (DD/ID) and autism spectrum disorders. In this study, we present the results of CMA analysis in patients with DD/ID. Of 210 patients, pathogenic CNVs were detected in 26 (12%) and variants of uncertain clinical significance in 36 (17%) children. The diagnosis of well-recognized genetic syndromes was achieved in 12 patients. CMA analysis revealed pathogenic de novo CNVs, such as 11p13 duplication with new clinical features. Our results support the utility of CMA as a routine diagnostic test for unexplained DD/ID.Entities:
Keywords: chromosomal microarray analysis; developmental delay; intellectual disability; microdeletion/microduplication
Year: 2018 PMID: 30775046 PMCID: PMC6375720 DOI: 10.1055/s-0038-1676583
Source DB: PubMed Journal: J Pediatr Genet ISSN: 2146-460X